These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12068182)

  • 21. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
    Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
    Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vimentin expression in the cervix.
    Stewart CJ; Little L
    Int J Gynecol Pathol; 2010 Jul; 29(4):402-3. PubMed ID: 20567157
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of microglandular adenocarcinoma of the endometrium.
    Karateke A; Haliloglu B; Atay V; Gurbuz A; Kir G
    Gynecol Oncol; 2005 Dec; 99(3):778-81. PubMed ID: 16229880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric-type Endocervical Adenocarcinoma Involving the Endometrium and Clinically Mimicking Endometrial Neoplasia: A Diagnostic Challenge.
    Busca A; Mirkovic J; Parra-Herran C
    Am J Surg Pathol; 2018 Jul; 42(7):983-985. PubMed ID: 29683820
    [No Abstract]   [Full Text] [Related]  

  • 25. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.
    Wahlström T; Lindgren J; Korhonen M; Seppälä M
    Lancet; 1979 Dec; 2(8153):1159-60. PubMed ID: 91890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesonephric hyperplasia in uterine cervix: report of two cases].
    Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adenocarcinoma of the cervix uteri].
    Frank GA; Andreeva IuIu; Zavalishina LE; Petrov AN
    Arkh Patol; 1999; 61(5):61-5. PubMed ID: 10598265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
    McCluggage WG; Jenkins D
    Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin.
    Plunkett M; Brestovac B; Thompson J; Sterrett G; Filion P; Smith D; Frost F
    Pathology; 2003 Oct; 35(5):397-401. PubMed ID: 14555383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
    Ohwada M; Suzuki M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphology, immunohistochemistry and differential diagnosis of 70 cases of adenocarcinoma of uterine cervix].
    Huang J
    Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):98-100. PubMed ID: 8403106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
    Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical pathological analysis and immunohistochemical expression of primary cervical adenocarcinoma in 98 cases].
    Zhu L; Li B
    Zhonghua Bing Li Xue Za Zhi; 1999 Aug; 28(4):252-5. PubMed ID: 11869532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sertoliform endometrial adenocarcinoma: a study of four cases.
    Eichhorn JH; Young RH; Clement PB
    Int J Gynecol Pathol; 1996 Apr; 15(2):119-26. PubMed ID: 8786200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma of the cervix and adenocarcinoma of the endometrium: distinction with PCR-mediated detection of HPV DNA.
    Hording U; Daugaard S; Visfeldt J
    APMIS; 1997 Apr; 105(4):313-6. PubMed ID: 9164475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical adenocarcinoma or cervical extension.
    Fruchter O
    Am J Obstet Gynecol; 1993 May; 168(5):1646-7. PubMed ID: 8498460
    [No Abstract]   [Full Text] [Related]  

  • 38. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
    Maes G; Fleuren GJ; Bara J; Nap M
    Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
    Barroeta JE; Pasha TL; Acs G; Zhang PJ
    Int J Gynecol Pathol; 2007 Jan; 26(1):76-82. PubMed ID: 17197901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.